Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors
Rudqvist N, et al.
Nature Communications
August 2023
Authors and Affiliates
Nils-Petter Rudqvist 1,2,3, Maud Charpentier 1, Claire Lhuillier 1,4, Erik Wennerberg 1,5, Sheila Spada 1, Caroline Sheridan 6, Xi Kathy Zhou 7, Tuo Zhang 8, Silvia C Formenti 1, Jennifer S Sims 9,10, Alicia Alonso 6, Sandra Demaria 11,12;
1 Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, 10065, USA.
2 Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson, Houston, TX, 77030, USA.
3 Department of Immunology, University of Texas MD Anderson, Houston, TX, 77030, USA.
4 Department of Immuno-Oncology, Sanofi, 94403, Vitry-sur-Seine, France.
5 Division of Radiotherapy and Imaging, Institute of Cancer Research, London, SM2 5NG, UK.
6 Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
7 Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, 10065, USA.
8 Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, 10065, USA.
9 Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
10 Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
11 Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, 10065, USA. szd3005@med.cornell.edu.
12 Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA. szd3005@med.cornell.edu.